Amedisys Inc

121.23-1.93-1.57%Vol 315.25K1Y Perf -32.83%
Aug 16th, 2022 16:00 DELAYED
BID99.99 ASK143.50
Open122.62 Previous Close123.16
Pre-Market- After-Market121.23
 - -  - -%
Target Price
164.73 
Analyst Rating
Moderate Buy 2.06
Potential %
35.88 
Finscreener Ranking
★★     45.73
Insiders Trans % 3/6/12 mo.
-100/-100/-78 
Value Ranking
★★+     48.26
Insiders Value % 3/6/12 mo.
-100/-100/-71 
Growth Ranking
★★★+     54.34
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-62 
Income Ranking
 —    -
Price Range Ratio 52W %
22.48 
Earnings Rating
Sell
Market Cap3.93B 
Earnings Date
27th Jul 2022
Alpha0.01 Standard Deviation0.13
Beta0.90 

Today's Price Range

118.90122.62

52W Range

101.61188.88

5 Year PE Ratio Range

24.20162.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.90%
1 Month
-3.59%
3 Months
-2.44%
6 Months
-15.37%
1 Year
-32.83%
3 Years
-8.86%
5 Years
146.55%
10 Years
729.77%

TickerPriceChg.Chg.%
AMED121.23-1.9300-1.57
AAPL173.03-0.1600-0.09
GOOG122.51-0.3700-0.30
MSFT292.71-0.7600-0.26
XOM91.46-0.8600-0.93
WFC46.060.31000.68
JNJ167.571.48000.89
FB196.640.99000.51
GE81.071.26001.58
JPM123.631.17000.96
 
ProfitabilityValueIndustryS&P 500US Markets
43.70
9.20
12.50
8.40
6.32
RevenueValueIndustryS&P 500US Markets
2.22B
68.30
7.24
9.01
Earnings HistoryEstimateReportedSurprise %
Q02 20221.231.4719.51
Q01 20221.111.2310.81
Q04 20211.171.180.85
Q03 20211.361.5312.50
Q02 20211.641.693.05
Q01 20211.431.547.69
Q04 20201.451.492.76
Q03 20201.272.2476.38
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.23-9.56Negative
9/2022 QR1.38-0.72Negative
12/2022 FY5.29-0.38Negative
12/2023 FY6.14-4.81Negative
Next Report Date-
Estimated EPS Next Report1.23
Estimates Count10
EPS Growth Next 5 Years %9.70
Volume Overview
Volume315.25K
Shares Outstanding32.44K
Shares Float28.28M
Trades Count8.24K
Dollar Volume38.07M
Avg. Volume351.72K
Avg. Weekly Volume231.63K
Avg. Monthly Volume399.42K
Avg. Quarterly Volume424.11K

Amedisys Inc (NASDAQ: AMED) stock closed at 121.23 per share at the end of the most recent trading day (a -1.57% change compared to the prior day closing price) with a volume of 315.25K shares and market capitalization of 3.93B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 21000 people. Amedisys Inc CEO is Paul B. Kusserow.

The one-year performance of Amedisys Inc stock is -32.83%, while year-to-date (YTD) performance is -25.11%. AMED stock has a five-year performance of 146.55%. Its 52-week range is between 101.61 and 188.88, which gives AMED stock a 52-week price range ratio of 22.48%

Amedisys Inc currently has a PE ratio of 28.50, a price-to-book (PB) ratio of 4.03, a price-to-sale (PS) ratio of 1.80, a price to cashflow ratio of 23.20, a PEG ratio of 2.32, a ROA of 7.79%, a ROC of 11.31% and a ROE of 15.09%. The company’s profit margin is 6.32%, its EBITDA margin is 12.50%, and its revenue ttm is $2.22 Billion , which makes it $68.30 revenue per share.

Of the last four earnings reports from Amedisys Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.23 for the next earnings report. Amedisys Inc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Amedisys Inc is Moderate Buy (2.06), with a target price of $164.73, which is +35.88% compared to the current price. The earnings rating for Amedisys Inc stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amedisys Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amedisys Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.01, ATR14 : 4.71, CCI20 : -36.58, Chaikin Money Flow : 0.14, MACD : 0.17, Money Flow Index : 32.36, ROC : 0.95, RSI : 54.64, STOCH (14,3) : 51.64, STOCH RSI : 0.91, UO : 52.12, Williams %R : -48.36), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amedisys Inc in the last 12-months were: David Kemmerly (Sold 2 500 shares of value $443 285 ), Denise M. Bohnert (Sold 557 shares of value $64 055 ), Paul B. Kusserow (Option Excercise at a value of $0), Richard A. Lechleiter (Buy at a value of $141 250)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (50.00 %)
8 (50.00 %)
8 (53.33 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
2 (13.33 %)
Hold
4 (25.00 %)
5 (31.25 %)
5 (33.33 %)
Moderate Sell
1 (6.25 %)
1 (6.25 %)
0 (0.00 %)
Strong Sell
1 (6.25 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.06
Moderate Buy
1.94
Moderate Buy
1.80

Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.

CEO: Paul B. Kusserow

Telephone: +1 225 292-2031

Address: 3854 American Way, Baton Rouge 70816, LA, US

Number of employees: 21 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

71%29%

Bearish Bullish

65%35%

TipRanks News for AMED


News

Stocktwits